Lung cancer screening: What do physicians say to reluctant patients and what do patients want them to say?

Patient Educ Couns

Divisions of Pulmonary/Critical Care Medicine and Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, MA, USA.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Lung cancer screening (LCS) can detect lung cancer at an earlier stage and reduce lung cancer mortality but can also cause harm. Therefore, physicians are tasked with conveying complex information to help patients make informed decisions. Studies suggest physicians often fall short of this. We characterize how physicians respond to a patient reluctant to undergo LCS and identify communication elements patients respond favorably to.

Method: Physicians responded to a vignette of a reluctant patient. Analogue patients (APs) rated responses and described their preferred response. We analyzed both physician and AP qualitative responses using content analysis and compared mean ratings of physician responses with a particular communication element present to responses without that element.

Results: We identified 19 communication elements in 42 physician responses and 24 elements in 64 AP responses. We identified 5 elements that were associated with higher AP ratings and how often physicians engaged in them (e.g., showing desire to understand the patient as a person, occurring in 21 % of responses.) CONCLUSION: We identify communication elements in physician and AP responses and reveal gaps between patients' desires and strategies employed by physicians.

Practical Implications: Findings suggest that incorporating specific communication behaviors may enhance patient receptivity regarding LCS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2025.108698DOI Listing

Publication Analysis

Top Keywords

lung cancer
16
communication elements
12
physician responses
12
cancer screening
8
identify communication
8
responses
8
elements physician
8
physicians
6
patients
5
communication
5

Similar Publications

Enantioselective Synthesis of Spirooxindole Derivatives through Lewis Acid-Catalyzed Michael Addition/Cyclization Cascade.

J Org Chem

September 2025

Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, P. R. of China.

A Mg(OTf)-catalyzed asymmetric Michael addition/cyclization cascade reaction between 3-isothiocyanato oxindoles and 2-arylidene-1,3-indanediones has been developed. This transformation provides an efficient and concise approach to biologically important bispiro[indanedione-oxindole-pyrrolidinyl]s under mild conditions in good to excellent yields (70-99% yields) with moderate to good stereoselectivities (up to 99% and >95:5 d.r.

View Article and Find Full Text PDF

Expanded senescent CD8 T-cells in IMID patients are associated with distinct inflammatory cytokines.

Clin Exp Immunol

September 2025

Rheumatology Department, Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1184, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (APHP), CEA , FHU CARE, Le Kremlin Bicêtre, France.

Introduction: Immunosenescence remodels immune functions and was first described with aging. It is present in 25% of cancer patients but has also been described in patients with Immune-mediated inflammatory diseases (IMIDs). This study aims at quantifying cells exhibiting a phenotype of senescence in CD4+ (T4sen) and CD8+ (T8sen) T cells, analyzing its potential drivers and the effect of anti-TNF treatment in a prospective cohort of patients with rheumatoid arthritis (RA), spondyloarthritis (SpA) and Sjögren disease (SjD).

View Article and Find Full Text PDF

Objectives: Bladder cancer is a common malignancy with high incidence and poor prognosis. N-methyladenosine (mA) modification is widely involved in diverse physiological processes, among which the mA recognition protein YTH N-methyladenosine RNA binding protein F2 (YTHDF2) plays a crucial role in bladder cancer progression. This study aims to elucidate the molecular mechanism by which O-linked -acetylglucosamine (O-GlcNAc) modification of YTHDF2 regulates its downstream target, period circadian regulator 1 (), thereby promoting bladder cancer cell proliferation.

View Article and Find Full Text PDF

Objectives: Non-small cell lung cancer (NSCLC) is associated with poor prognosis, with 30% of patients diagnosed at an advanced stage. Mutations in the and genes are important prognostic factors for NSCLC, and targeted therapies can significantly improve survival in these patients. Although tissue biopsy remains the gold standard for detecting gene mutations, it has limitations, including invasiveness, sampling errors due to tumor heterogeneity, and poor reproducibility.

View Article and Find Full Text PDF

Aims: We aimed to analyze CD63, a cell surface protein that has been associated with tumor aggressiveness in several cancers, including breast, colorectal, and lung cancer, as well as melanoma, in prostate cancer.

Methods: CD63 expression was analyzed immunohistochemically in a cohort of primary prostate cancers from 281 patients. The results were correlated with clinico-pathologic parameters, including biochemical recurrence.

View Article and Find Full Text PDF